Ernexa Therapeutics’ “Trojan Horse” stem cells can infiltrate ovarian tumors in mice, boosting T cell activity and leading to ...

More information: Amy L. Wilson et al, Leader cells promote immunosuppression to drive ovarian cancer progression in vivo, Cell Reports (2024). DOI: 10.1016/j.celrep.2024.114979 Journal ...

Researchers at the University of Pittsburgh have identified a novel trigger of a deadly form of ovarian cancer. Discovery of a subset of high-risk progenitor cells that reside in fallopian tube ...

In particular, natural killer cells, are emerging as an optimal cell target for immunotherapy in ovarian cancer. Natural killer cells are a type of white blood cell responsible for eliminating ...

"Our results demonstrate that aNK cells have great potential for treating cancer, especially for patients with difficult-to-treat ovarian cancer," says Dhifaf Sarhan, senior lecturer at the ...

called adaptive NK cells, to remember ovarian tumors and effectively attack them. The discovery, published in Cancer Immunology Research, could pave the way for new, more powerful immunotherapies for ...

Northwestern Medicine scientists have uncovered new details about the genetic structure of ovarian cancer stem cells, according to a study published in Advanced Science. Inside cells, DNA mixes ...

"Our results demonstrate that aNK cells have great potential for treating cancer, especially for patients with difficult-to-treat ovarian cancer," says Dhifaf Sarhan, senior lecturer at the ...

The paper is titled "Adaptive NK Cells Exhibit Tumour-Specific Immune Memory and Cytotoxicity in Ovarian Cancer." Adaptive NK cells, aNK cells, are a subset of NK cells that can remember past ...